Jason P Sinnwell Selected Research

Castration

12/2022	Molecular Profile Changes in Patients with Castrate-Resistant Prostate Cancer Pre- and Post-Abiraterone/Prednisone Treatment.
1/2022	Biomarkers for Predicting Abiraterone Treatment Outcome and Selecting Alternative Therapies in Castration-Resistant Prostate Cancer.
3/2019	A Prospective Correlation of Tissue Histopathology With Nucleic Acid Yield in Metastatic Castration-Resistant Prostate Cancer Biopsy Specimens.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jason P Sinnwell Research Topics

Disease

13	Neoplasms (Cancer) 03/2024 - 05/2007
12	Breast Neoplasms (Breast Cancer) 12/2023 - 09/2015
4	Prostatic Neoplasms (Prostate Cancer) 12/2022 - 04/2016
3	Triple Negative Breast Neoplasms 06/2022 - 01/2017
2	Genetic Risk Score 12/2023 - 01/2021
1	Monoclonal Gammopathy of Undetermined Significance 01/2022
1	Type 2 Diabetes Mellitus (MODY) 01/2022
1	Coronary Disease (Coronary Heart Disease) 01/2022
1	Peripheral Arterial Disease 01/2022
1	Vascular Diseases (Vascular Disease) 01/2022
1	Pathologic Complete Response 01/2017
1	renal Oncocytoma 09/2009
1	Renal Cell Carcinoma (Grawitz Tumor) 09/2009
1	Genetic Translocation (Chromosomal Translocation) 09/2009
1	Embryonal Carcinoma 05/2007
1	Rhabdomyosarcoma 05/2007
1	Leiomyosarcoma 05/2007

Drug/Important Bio-Agent (IBA)

3	Biomarkers (Surrogate Marker)IBA 03/2024 - 01/2022
3	Phenobarbital (Luminal)FDA Link 06/2022 - 01/2017
2	abirateroneIBA 12/2022 - 01/2022
2	Androgen Receptors (Androgen Receptor)IBA 06/2022 - 01/2017
2	Proteins (Proteins, Gene)FDA Link 01/2022 - 05/2007
2	Trastuzumab (Herceptin)FDA Link 01/2021 - 12/2017
2	AnthracyclinesIBA 01/2021 - 12/2017
2	taxaneIBA 01/2021 - 12/2017
2	Estrogen ReceptorsIBA 10/2019 - 01/2018
2	olaparibIBA 12/2018 - 01/2017
1	TubulinIBA 01/2023
1	Prednisone (Sone)FDA LinkGeneric 12/2022
1	Abiraterone AcetateIBA 12/2022
1	Estrogen Receptor betaIBA 02/2022
1	LipidsIBA 01/2022
1	Aromatase InhibitorsIBA 10/2019
1	Nucleic AcidsIBA 03/2019
1	DNA (Deoxyribonucleic Acid)IBA 03/2019
1	RNA (Ribonucleic Acid)IBA 03/2019
1	GlucocorticoidsIBA 01/2018
1	Glucocorticoid Receptors (Glucocorticoid Receptor)IBA 01/2018
1	Steroid Receptors (Steroid Receptor)IBA 01/2017
1	AndrogensIBA 04/2016
1	Cyclin D1IBA 09/2009
1	Anaplastic Lymphoma KinaseIBA 05/2007
1	AntigensIBA 05/2007
1	Keratins (Keratin)IBA 05/2007

Therapy/Procedure

10	Therapeutics 03/2024 - 09/2015
6	Drug Therapy (Chemotherapy) 01/2023 - 01/2017
6	Neoadjuvant Therapy 06/2022 - 09/2015
3	Castration 12/2022 - 03/2019
1	Complementary Therapies (Alternative Medicine) 01/2022
1	Precision Medicine 12/2018
1	Adjuvant Chemotherapy 01/2018